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Li et al., page 245
Although recent studies have clearly demonstrated that de-
mographic changes led to the accumulation of a large
number of rare variants in the human genome, no
consensus has been reached with regard to how these var-
iants contribute to human health and disease. Divergent
interpretations of sequencing studies and theoretical
models continue to drive the common disease–common
variant versus common disease–rare variant debate. More-
over, available algorithms continue to struggle with inter-
preting the vast noncoding portion of the genome. In
this issue, Li et al. combined genomic and transcriptomic
data from a large, multigenerational family to begin to
quantify the impact of rare noncoding variants on gene
expression. The authors found an enrichment of rare regu-
latory and splicing variants in expression quantitative trait
loci of large effect and showed that—on the basis of cur-
rent annotations—these variants are more likely to influ-
ence genes with known roles in complex disorders.
Study-design limitations precluded the incorporation of
family health data into their analysis; nevertheless, the
work represents a step forward in—as well as an analytical
framework for—the interpretation of genomes in the
context of health and disease.NOTCH1 Mutations in Adams-Oliver Syndrome
Stittrich et al., page 275
Adams-Oliver syndrome (AOS) is a rare disease character-
ized by transverse limb defects and the absence of skin
on the scalp; however, clinical features are variable in
that cardiac abnormalities and vascular malformations
have been reported. Perhaps not surprisingly then, causa-
tive mutations have been identified in several genes,
including some with described roles in key developmental
pathways. Notably, mutations have been identified in
genes whose proteins products transmit and regulate
Notch signaling, a pathway that specifies cell fate in
many organ systems. In this issue, Stittrich et al. found het-
erozygous NOTCH1 mutations in individuals with AOS.
NOTCH1 mutations have been associated with a variety
of human cancers, as well as severe vascular defects. The
majority of the families described by Stittrich et al. dis-
played cardiac and vascular abnormalities, and the authors1Scientific Editor, AJHG; 2Deputy Editor, AJHG
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The Americansuggest that the vascular disruption could in fact be consid-
ered a root cause of the limb and scalp defects that typify
AOS. Additional research utilizing mouse models, cell
biology, and information gathered from AOS-affected
families will be required for a full evaluation of this hy-
pothesis as well as for a mechanistic understanding of
how dysregulation of the Notch pathway causes the de-
fects seen in AOS.Limiting False Gene-Environment Associations
Dudbridge et al., page 301
Genome-wide association studies (GWASs) have produced
vast numbers of tag SNPs associated with various traits,
andwork aimed at unraveling exactlyhow these SNPs affect
particular phenotypes is ongoing. Many times, follow-up
studies investigate the role of a particular tag SNP in relation
to environmental or other genetic loci, but some evidence
indicates that this could lead to false-positive associations.
In this study,Dudbridge et al. demonstratedhowgene-envi-
ronment interactionsmightbebiasedwhen these statistical
models are used for inferring biological interaction. As an
example, a marker SNP in CYP3A is associated with levels
of urinary estrone gluconide andageofmenarche. The asso-
ciation between this SNP and age at menarche seemed to
regulate breast cancer risk; however, after the authors
applied their analysis, it appeared that the interaction was
most likely an indication that the tag SNP was in perfect
linkage disequilibrium (LD) with a low-frequency variant
of strong effect. The authors’ work also has implications
for measuring gene-gene interactions. Many of the gene-
gene interaction pairs that are measured by GWAS SNPs
could be explained by both of the SNPs’ being in LD with
a single, causal SNP rather than a true gene-gene interac-
tion. To address these issues in gene-environment studies,
the authors suggest routinely performing a sensitivity anal-
ysis to allow for gene-environment dependence and imper-
fect LD between tag and causal SNPs.An Epithelial-Junction Disruption
Petrof et al., page 308
The grainyhead family of transcription factors influences
the development of epithelial tissue by regulating the
expression of genes involved in cell junctions. Grainy-
head-like protein 2 (GRHL2), in particular, has beeny of Human Genetics. All rights reserved.
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ascribed roles in wound healing and neural-tube closure.
To date, however, GRHL2 mutations have been identified
only in individuals with autosomal-dominant hearing
loss, leaving the role of GRHL2 in human skin pathology
unclear. In this issue, Petrof et al. identified homozygous
GRHL2 mutations in two families affected by ectodermal
dysplasia. Cells from affected individuals displayed defec-
tive cell-junction formation and readily detached from a
fibronectin substratum. Expression profiling revealed
marked differences between normal and mutant skin,
including in pathways related to cytoskeletal remodeling,
cell adhesion, and lipid biosynthesis. Future experiments
will be needed for defining which pathways are altered in
specific cell types. The majority of our understanding of
the grainyhead proteins comes from experiments in
mice, and so these new findings open the door for several
lines of research to shed light on themechanisms bywhich
GRHL2, as well as its family members, contributes to hu-
man development and pathology.COX Deficiency and a SharedMRI Pattern Uncover
APOPT1 Mutations
Melchionda et al., page 315
Although cytochrome c oxidase (COX) deficiency is a com-
mon hallmark of mitochondrial disorders, many individ-
uals with COX deficiency lack a genetic diagnosis. In this242 The American Journal of Human Genetics 95, 241–242, Septembstudy, Melchionda et al. used exome sequencing to iden-
tify APOPT1 mutations that cause a mitochondrial defect
in two unrelated families. The similarities in the brain
MRI patterns shared between these individuals were spe-
cific and distinctive: early and rapid onset of cavitating
leukodystrophy primarily in the posterior cerebral white
matter and corpus callosum. Because of this unique
pattern, three additional affected individuals were
screened for APOPT1mutations. These six individuals pre-
sented with COX deficiency, peripheral neuropathy, and
distinctive cavitating leukodystrophy with a variable age
of onset ranging from infancy to childhood. To investigate
how defects in APOPT1 might lead to this phenotype, the
authors performed several functional studies. Although
APOPT1 did not accumulate under normal conditions, it
did accumulate when the cells were subjected to oxidative
stress, indicating that APOPT1 might have a role in the
mitochondrial response to reactive oxygen species. Previ-
ous studies have suggested that APOPT1 might also play
a role in apoptosis, but no observable difference in
apoptotic cells between mutant and wild-type fibroblasts
could be identified. Instead, APOPT1 might be important
for complex IV assembly or stability. As phenotyping and
sharing of genetic data improve, clarification of gene-
phenotype or allele-phenotype associations across many
heterogeneous disorders might show that unrecognized
subgroups of individuals within these cohorts share phe-
notypes and thus also mutations in the same gene.er 4, 2014
